Product Comparison

Comparison Options

• Print
• Email

McKesson #	972202	479124	788329	652633	883081
Description	Zolinza® Vorinostat 100 mg Capsule 120 Capsules	Fluorouracil 50 mg / mL Injection 10 mL	Fluorouracil 50 mg / mL Injection 50 mL	Methotrexate Sodium 25 mg / mL Injection 10 mL	Anastrozole 1 mg Tablet 30 Tablets
Manufacturer #	00006056840	63323011710	63323011751	63323012310	16729003510
Brand	Zolinza®
Manufacturer	Schering Plough	APP Pharmaceuticals	Fresenius USA	Fresenius USA	Accord Healthcare
Invoice	ZOLINZA, CAP 100MG (120/BT)D/SD/S MERCKD	FLUOROURACIL, SDV 50MG/ML 10ML(10/CT)	FLUOROURACIL, VL 2.5GM/50ML 50ML	METHOTREXATE, MDV 25MG/ML 10ML	ANASTROZOLE, TAB 1MG (30/BT)9A
	Log In to Order	Log In to Order	Log In to Order	Log In to Order	Log In to Order
Comparison
Alternate Manufacturer Number		1327261	1281526	2229607	2701043
Container Type	Bottle	Single-Dose Vial	Pharmacy Bulk Vial	Multiple-Dose Vial	Bottle
Country of Origin	United States	Unknown	Unknown	Unknown	Unknown
Dosage Form	Capsule	Injection	Injection	Injection	Tablet
Generic Drug Code	97345	97455	97457	38466	24410
Generic Drug Name	Vorinostat	Fluorouracil	Fluorouracil	Methotrexate Sodium	Anastrozole
NDC Number	00006056840	63323011710	63323011751	63323012310	16729003510
Product Dating	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days	McKesson Acceptable Dating: we will ship >= 90 days
Quantity	120 Capsules				30 Tablets
Strength	100 mg	50 mg / mL	50 mg / mL	25 mg / mL	1 mg
Type		Intravenous	Intravenous	Intramuscular, Intravenous, or Intra-arterial
UNSPSC Code	51111774	51442004	51442004	51202203	51111875
Volume		10 mL	50 mL	10 mL
Application	Antineoplastic Agent	Antineoplastic Agent	Antineoplastic Agent	Antineoplastic Agent	Antineoplastic Agent
Features and Benefits	Direct contact with the powder in Zolinza capsules with the skin or mucous membranes should be avoided			Contains preservative Sterile Isotonic Liquid Not for intrathecal use